First Time Loading...

Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 0.7281 USD 4.01% Market Closed
Updated: Mar 29, 2024

Wall Street
Price Targets

BNR Price Targets Summary
Burning Rock Biotech Ltd

Wall Street analysts forecast BNR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNR is 4.0392 USD with a low forecast of 3.9996 USD and a high forecast of 4.158 USD.

Lowest
Price Target
3.9996 USD
449% Upside
Average
Price Target
4.0392 USD
455% Upside
Highest
Price Target
4.158 USD
471% Upside
Burning Rock Biotech Ltd Competitors:
Price Targets
YMAB
Y-mAbs Therapeutics Inc
25% Upside
MAB
Mabion SA
4% Downside
IOVA
Iovance Biotherapeutics Inc
78% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
29% Upside
ALVO
Alvotech SA
22% Upside
TNGX
Tango Therapeutics Inc
124% Upside
IMCR
Immunocore Holdings PLC
30% Upside
VITR
Vitrolife AB
22% Upside

Revenue
Forecast

Revenue Estimate
Burning Rock Biotech Ltd

For the last 4 years the compound annual growth rate for Burning Rock Biotech Ltd's revenue is 28%. The projected CAGR for the next 4 years is 19%.

28%
Past Growth
19%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Burning Rock Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
35%
Average Beat

Net Income
Forecast

Net Income Estimate
Burning Rock Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
46%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNR's stock price target?
Price Target
4.0392 USD

According to Wall Street analysts, the average 1-year price target for BNR is 4.0392 USD with a low forecast of 3.9996 USD and a high forecast of 4.158 USD.

What is Burning Rock Biotech Ltd's Revenue forecast?
Projected CAGR
19%

For the last 4 years the compound annual growth rate for Burning Rock Biotech Ltd's revenue is 28%. The projected CAGR for the next 4 years is 19%.